Epidemiology, outcome, targeted agents and immunotherapy in adolescent and young adult non‐Hodgkin and Hodgkin lymphoma. (6th February 2019)

• Record Type: Journal Article
• Authors: Metzger, Monika L.; Mauz‐Körholz, Christine
• Other Names: Cairo Mitchell S. guestEditor.
• Is Part Of: British journal of haematology. Volume 185:Number 6(2019)
• Page Start: 1142
• Page End: 1157
• Publication Date: 2019-02-06
• Subjects: Hodgkin lymphoma -- non‐Hodgkin lymphoma -- antibody therapy -- cellular immunotherapy -- vaccine therapy -- chimeric antigen receptor; Hematology -- Periodicals; Blood -- Diseases -- Periodicals; 616.15
• DOI: 10.1111/bjh.15789
• Languages: English
• ISSNs: 0007-1048

Abstract

Summary: The epidemiology, outcome and targeted immunotherapy in adolescent and young adult non‐Hodgkin and Hodgkin lymphoma were discussed during the 6th International Symposium on Childhood, Adolescent and Young Adult Non‐Hodgkin Lymphoma September 26th–29th 2018 in Rotterdam, the Netherlands. This review summarizes some of those presentations, as well as other current and novel antibody therapy, immune check‐point inhibitors, chimeric antigen receptor T cells, cancer vaccines and cytotoxic T lymphocyte therapy.